非上市公司路演专场

返回主日程
09:00 - 12:40
  • 主持人 Moderator
  • 何风志, 北康医疗投资总经理
  • HE Fengzhi, General Manager of BK Healthcare Capital
    • 交流嘉宾 Invited Discussants:
  • 邓婷, 赛诺菲全球注册事务大中华区注册事务负责人以及研发中国负责人
  • DENG Ting, Head of GRA Greater China & RnD China Lead, Sanofi
  • 何风志, 北康医疗投资总经理
  • HE Fengzhi, General Manager of BK Healthcare Capital
  • 朱国广, 东吴证券研究所联席所长、大消费组组长、医药行业首席分析师
  • ZHU Guoguang, Co-Director of the Institute, Leader of Consumer Sector Group, Chief Analyst for Healthcare Sector, Soochow Securities
09:00 - 09:20
  • 主题报告
  • Keynote Speech
  • 中国创新药的全球竞争力
  • Global Competitiveness of China’s Innovative Drugs
  • 朱国广, 东吴证券研究所联席所长、大消费组组长、医药行业首席分析师
  • ZHU Guoguang, Co-Director of the Institute, Leader of Consumer Sector Group, Chief Analyst for Healthcare Sector, Soochow Securities
09:20 - 09:45
  • 项目1
  • Project 1
  • tAIM：热物理自适应免疫调节平台
  • Platform tAIM: Thermo-physical Adaptive Immune Modulator
  • 孙建奇, 上海美杰医疗科技有限公司董事长
  • SUN Jianqi, Chairman of Shanghai MAaGI Medical Technology Co., Ltd.
09:45 - 10:10
  • 项目2
  • Project 2
  • 固体自乳化免疫制剂
  • Solid Self-Emulsifying Immunoformulation
  • 蒯锐, 清华大学副教授
  • KUAI Rui, Associate Professor of Tsinghua University
10:10 - 10:35
  • 项目3
  • Project 3
  • CRET宽域集成检测——从小分子到细胞 全尺度精准检测
  • CRET Wide-Range Integrated Detection–Full-Scale Precision Analysis from Small Molecules to Cells
  • 曹丹, 南京浦光生物科技有限公司总经理
  • CAO Dan, General Manager of Nanjing Poclight Biotechnology Co.,Ltd
10:35 - 11:00
  • 项目4
  • Project 4
  • 重塑脓毒症免疫稳态的脂质体药物
  • A Liposomal Therapy to Restore Immune Homeostasis in Sepsis
  • 薛向东, 上海交通大学副教授
  • XUE Xiangdong, Associate Professor of Shanghai Jiao Tong University
11:00 - 11:25
  • 项目5
  • Project 5
  • 治疗类风湿性关节炎的肉桂醛前药平台
  • Cinnamaldehyde-based Prodrugs for Rheumatoid Arthritis Treatment
  • 温淑娴, 信诺思健康科技有限公司首席运营官
  • WEN Shuxian, Chief Operating Officer of Cinnotis Ltd
11:25 - 11:50
  • 项目6
  • Project 6
  • 从临床耐药标本逆向发现新靶点（患者来源模型平台及验证）管线
  • Reverse-Engineering Resistance Targets from Patient Samples: A Patient-Derived Model Platform and Three Validated Programs
  • 吴立宇, 上海立迪生物技术股份有限公司全球商务拓展副总裁
  • WU Liyu, VP of Global BD, Shanghai LIDE Biotech, Co., Ltd.
11:50 - 12:15
  • 项目7
  • Project 7
  • 潜在的膀胱癌根治性病毒治疗技术平台
  • Potential Novel Curative Viral Therapy for Bladder Cancer
  • 赵宏, 苏州映辉医药科技有限公司BD总监
  • James ZHAO, BD Director of Suzhou Infinory Pharmaceutical Technology Co., Ltd.
12:15 - 12:40
  • 项目8
  • Project 8
  • 智能听觉赋能现代医疗
  • Intelligent Hearing Empowers Modern Healthcare
  • 王黎明, 北京远鉴信息技术有限公司董事长
  • WANG Liming, Chairman of Beijing Yuanjian Information Technology Co., Ltd.